Literature DB >> 683411

Influence of taurine dosage on cobalt epilepsy in mice.

D I Carruthers-Jones, N M van Gelder.   

Abstract

The present work addresses itself to answering several questions in relations to the antiepileptic action of taurine (see "Introduction"). For this purpose, cobalt epileptic mice, treated with isoosmolar saline or not treated, was compared with groups of mice that had received doses of taurine varying between 1.0 and 10.0 mg/kg. Whereas all the taurine doses employed effectively reduced seizure incidence, with 10.0 mg/kg giving the best results, none of these doses had ameliorated the amino acid abnormalities in the cortex after two days of treatment in comparison with the group that had received isoosmolar saline. On the contrary, the largest amino acid abnormalities occurred in the group of mice (10.0 mg/kg) that had improved the most clinically. We conclude that the acute antiseizure action of taurine, and its effect on restoring normal amino acid patterns in the cortex, represent two separate properties of taurine.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 683411     DOI: 10.1007/BF00964364

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  14 in total

1.  Concentration of amino acids in the brain of cobalt-epileptic rat.

Authors:  C R Craig; E R Hartman
Journal:  Epilepsia       Date:  1973-12       Impact factor: 5.864

2.  Antagonism by taurine of cobalt induced epilepsy in cat and mouse.

Authors:  N M Van Gelder
Journal:  Brain Res       Date:  1972-11-27       Impact factor: 3.252

3.  Convulsions and the gamma-aminobutyric acid content of rat brain.

Authors:  F V DeFeudis; K A Elliott
Journal:  Can J Physiol Pharmacol       Date:  1968-09       Impact factor: 2.273

4.  Glutamate dehydrogenase, glutamic acid decarboxylase, and GABA amino transferase in epileptic mouse cortex.

Authors:  N M van Gelder
Journal:  Can J Physiol Pharmacol       Date:  1974-10       Impact factor: 2.273

5.  Close correlation between changing content of specific amino acids in epileptogenic cortex of cats, and severity of epilepsy.

Authors:  N M Van Gelder; A Courtois
Journal:  Brain Res       Date:  1972-08-25       Impact factor: 3.252

6.  Amino acid content of epileptogenic human brain: focal versus surrounding regions.

Authors:  N M Van Gelder; A L Sherwin; T Rasmussen
Journal:  Brain Res       Date:  1972-05-26       Impact factor: 3.252

7.  Glutamine synthetase: glial localization in brain.

Authors:  A Martinez-Hernandez; K P Bell; M D Norenberg
Journal:  Science       Date:  1977-03-25       Impact factor: 47.728

8.  Levels of free amino acids in serum and cerebrospinal fluid after administration of taurine to epileptic and normal subjects.

Authors:  R Mutani; F Monaco; L Durelli; M Delsedime
Journal:  Epilepsia       Date:  1975-12       Impact factor: 5.864

9.  Taurine treatment of spontaneous chronic epilepsy in a cat.

Authors:  N M van Gelder; I Koyama; H H Jasper
Journal:  Epilepsia       Date:  1977-03       Impact factor: 5.864

10.  A specific protein abnormality associated with cobalt-induced epilepsy in mice.

Authors:  M Greaves; M Bélanger; N M van Gelder
Journal:  Neurochem Res       Date:  1976-06       Impact factor: 3.996

View more
  2 in total

1.  Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia.

Authors:  Ming Sun; Chao Xu
Journal:  Cell Mol Neurobiol       Date:  2007-08-22       Impact factor: 5.046

Review 2.  Review: taurine: a "very essential" amino acid.

Authors:  Harris Ripps; Wen Shen
Journal:  Mol Vis       Date:  2012-11-12       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.